| Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover | Ben Fidler | 02/20/15 | Boston |
| East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition | Ben Fidler | 01/09/15 | Boston |
| Sage’s Drug For Rare Epilepsy Shows Promise in Small Study | Ben Fidler | 11/10/14 | Boston |
| Epilepsy Device Pioneer Cyberonics Still Evolving After 25 Years | Bernadette Tansey | 05/28/13 | Texas |
| Sage Therapeutics Shifts Gears, Focuses on Rare Form of Epilepsy | Ben Fidler | 04/17/13 | Boston |
| At Metcalfe’s Party for MIT $100K Finalists, a Preview of Startups Presenting at Tonight’s Finale | Gregory T. Huang | 05/11/11 | Boston |
| Glaxo, Xenoport Win FDA Green Light to Treat Restless Leg Syndrome; Shares Boom | Luke Timmerman | 04/06/11 | San Francisco |
| PatientsLikeMe Growing as Pharma Customers Boost Focus on Patients | Ryan McBride | 02/10/10 | Boston |
| Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood | Luke Timmerman | 02/04/10 | Boston |
| NeuroVista, Emerging from Stealth Mode, Unveils Technology to Predict Epileptic Seizures | Luke Timmerman | 07/28/08 | Seattle |
| Sepracor Licenses Epilepsy Drug | Robert Buderi | 01/02/08 | Boston |
